McConkey DJ - Search Results

1

Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome.

Bold RJ, Virudachalam S, McConkey DJ. Bold RJ, et al. Among authors: mcconkey dj. J Surg Res. 2001 Sep;100(1):11-7. doi: 10.1006/jsre.2001.6194. J Surg Res. 2001. PMID: 11516199

2

Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content.

Bold RJ, Chandra J, McConkey DJ. Bold RJ, et al. Among authors: mcconkey dj. Ann Surg Oncol. 1999 Apr-May;6(3):279-85. doi: 10.1007/s10434-999-0279-x. Ann Surg Oncol. 1999. PMID: 10340887

3

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments].

Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B, Roth JA. Bouvet M, et al. Among authors: mcconkey dj. Ann Surg Oncol. 1998 Dec;5(8):681-8. doi: 10.1007/BF02303477. Ann Surg Oncol. 1998. PMID: 9869513

4

Apoptosis, cancer and cancer therapy.

Bold RJ, Termuhlen PM, McConkey DJ. Bold RJ, et al. Among authors: mcconkey dj. Surg Oncol. 1997 Nov;6(3):133-42. doi: 10.1016/s0960-7404(97)00015-7. Surg Oncol. 1997. PMID: 9576629 Review.

5

BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines.

Bold RJ, Virudachalam S, McConkey DJ. Bold RJ, et al. Among authors: mcconkey dj. Cancer. 2001 Sep 1;92(5):1122-9. doi: 10.1002/1097-0142(20010901)92:5<1122::aid-cncr1429>3.0.co;2-h. Cancer. 2001. PMID: 11571724

6

Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line.

McConkey DJ, Greene G, Pettaway CA. McConkey DJ, et al. Cancer Res. 1996 Dec 15;56(24):5594-9. Cancer Res. 1996. PMID: 8971161

7

Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors.

Zheng B, Georgakis GV, Li Y, Bharti A, McConkey D, Aggarwal BB, Younes A. Zheng B, et al. Clin Cancer Res. 2004 May 1;10(9):3207-15. doi: 10.1158/1078-0432.ccr-03-0494. Clin Cancer Res. 2004. PMID: 15131062

8

Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG.

Liu H, Zhang T, Chen R, McConkey DJ, Ward JF, Curley SA. Liu H, et al. Among authors: mcconkey dj. J Surg Res. 2012 Jul;176(1):147-53. doi: 10.1016/j.jss.2011.09.017. Epub 2011 Oct 5. J Surg Res. 2012. PMID: 22099584

9

Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.

Pan X, Arumugam T, Yamamoto T, Levin PA, Ramachandran V, Ji B, Lopez-Berestein G, Vivas-Mejia PE, Sood AK, McConkey DJ, Logsdon CD. Pan X, et al. Among authors: mcconkey dj. Clin Cancer Res. 2008 Dec 15;14(24):8143-51. doi: 10.1158/1078-0432.CCR-08-1539. Clin Cancer Res. 2008. PMID: 19088029 Free PMC article.

10

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.

Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey DJ, Choi W. Arumugam T, et al. Among authors: mcconkey dj. Cancer Res. 2009 Jul 15;69(14):5820-8. doi: 10.1158/0008-5472.CAN-08-2819. Epub 2009 Jul 7. Cancer Res. 2009. PMID: 19584296 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results